BioCurex Inc., headquartered in the Vancouver area, has completed the incorporation process for a fully-owned subsidiary, BioCurex China, which will be sited in Shanghai. The new company will operate initially as a clinical laboratory that will perform cancer tests, using BioCurex’s proprietary RECAF™ technology. More details...
Stock Symbol: (OTCBB: BOCX) (NYSE: ABT)
Sorry... this feature or article is only available to subscribers.